IP Verse

Human Monoclonal Antibody Human Cd134 (Ox40) And Methods Of Making And Using Same

Patent No. EP1951760 (titled "Human Monoclonal Antibody Human Cd134 (Ox40) And Methods Of Making And Using Same") was filed by Kirin Pharma Kabushiki Kaisha on Nov 27, 2006. The application was issued on Mar 18, 2020.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANMay 26, 2017MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1951760

KIRIN PHARMA KABUSHIKI KAISHA
Application Number
EP06838473A
Filing Date
Nov 27, 2006
Status
Patent Maintained As Amended
Feb 14, 2020
Publication Date
Mar 18, 2020
External Links
Slate, Register , Google Patents